
Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches
Number of patients reached in 2024 jumps 8% to 66 million. In 2024, Boehringer Ingelheim in India, Middle East, Turkey and Africa (IMETA) region achieved net sales of EUR 855 million, reflecting a 17% increase compared to the previous year. R&D …